Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Cytiva BioProcess R&D AB

Closing information (x1000 EUR)

Closing information 2022/12 2021/12 2020/12
Turnover 1,528,690 Less Arrow 1,445,823 Less Arrow 992,082
Financial expenses 1,037 More Arrow 1,291 Less Arrow 1,190
Earnings before taxes 889,799 Less Arrow 770,944 Less Arrow 320,099
EBITDA 1,481,410 Less Arrow 1,415,350 Less Arrow 976,539
Total assets 3,182,048 Less Arrow 2,596,586 More Arrow 4,131,385
Current assets 1,183,650 Less Arrow 24,127 More Arrow 855,137
Current liabilities 2,055,895 Less Arrow 1,314,615 Less Arrow 86,571
Equity capital 1,036,457 More Arrow 1,042,884 More Arrow 3,735,698
- share capital 9 More Arrow 10 Equal arrow 10
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 32.6% More Arrow 40.2% More Arrow 90.4%
Turnover per employee
Profit as a percentage of turnover 58.2% Less Arrow 53.3% Less Arrow 32.3%
Return on assets (ROA) 28.0% More Arrow 29.7% Less Arrow 7.8%
Current ratio 57.6% Less Arrow 1.8% More Arrow 987.8%
Return on equity (ROE) 85.9% Less Arrow 73.9% Less Arrow 8.6%
Change turnover 199,980 More Arrow 472,114 Less Arrow 315,605
Change turnover % 15% More Arrow 48% Less Arrow 47%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.